Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Denikitug (GS-1811) alone or with Zimberelimab in adults with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Denikitug (GS-1811)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Gilead Sciences | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING